Clinical

Dataset Information

0

Colorectal Cancer Metastatic


ABSTRACT: Primary Objective: To evaluate the safety of aflibercept in participants with mCRC treated with irinotecan/5-Fluorouracil (5-FU) combination (FOLFIRI) after failure of an oxaliplatin-based regimen (participants similar to those evaluated in the VELOUR trial [EFC10262, NCT00561470]) according to side effects prevention and management guidelines. Secondary Objective: To document the Health-Related Quality of Life (HRQL) of aflibercept in this participant population.

DISEASE(S): Colorectal Neoplasms,Colorectal Cancer Metastatic

PROVIDER: 2130809 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2123274 | ecrin-mdr-crc
2026-07-09 | GSE338073 | GEO
2021-03-20 | GSE169230 | GEO
2014-08-31 | E-MTAB-2883 | biostudies-arrayexpress
2014-09-04 | E-MTAB-2884 | biostudies-arrayexpress
2023-06-21 | GSE220622 | GEO
2023-06-21 | GSE221615 | GEO
2025-11-17 | PXD045926 | Pride
2022-04-28 | GSE201482 | GEO
2022-04-28 | GSE201481 | GEO